In negative-for-alpha-thalassemia group, 12038 participants were tested for MCV, MCH and HbA2 simultaneously, 1162 participants were tested for MCVand MCH only, 430 participants were tested for HbA2 only. This evidence concerns the gene HBA2 and alpha thalassemia spectrum.